From theory to practice: the versatility of drug-coated balloons around the world

Sponsored by B. Braun

Anchorperson: P. Lemos

Spokesperson: B. Scheller

Summary

Step into the world of drug-coated balloons (DCBs) with this EuroPCR 2025 session, tracing their journey from pioneering use in Europe to versatile applications worldwide. Discover the latest evidence on the safety and efficacy of both paclitaxel- and sirolimus-coated balloons across diverse lesion types—from straightforward to complex cases involving large vessels, bifurcations, multivessel disease, and CTOs. Benefit from practical insights on simplifying PCI, including hybrid approaches combining DCBs with intravascular lithotripsy for calcified lesions. Understand how metall-free PCI is influencing STEMI treatment, and get an OCT-guided perspective on sirolimus performance. This session offers a comprehensive look at how DCBs are shaping the future of coronary intervention.

Learning Objectives

To learn more about the safety and effectiveness of the best-investigated coronary drug-coated balloons
To learn how drug-coated balloons are used in a variety of settings around the world
To gain confidence in using drug-coated balloon with a data-driven treatment choice
To gain an understanding how drug-coated balloon can reduce complexity in today’s PCI
To gain an understanding of the active drug-coated balloon coatings paclitaxel and sirolimus and their strength in various indications
To receive the latest clinical insights into the available data for drug-coated balloon usage in de-novo lesions
To learn about practical experiences on drug-coated balloon in large vessels, bifurcations, multivessel disease and CTO
To get an understanding how to use the hybrid approach especially for challenging lesions to improve clinical outcome